Patent details

Basic Information

Publication number:

EP3389660

PCT Application Number:

US2016065503

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP168165637

PCT Publication Number:

WO2017105982

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION THERAPY FOR CANCER

French Title of Invention:

POLYTHÉRAPIE CONTRE LE CANCER

German Title of Invention:

KOMBINATIONSTHERAPIE GEGEN KREBS

SPC Number:

Dates

Filing date:

08/12/2016

Grant date:

16/10/2019

EP Publication Date:

24/10/2018

PCT Publication Date:

22/06/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/10/2019

EP B1 Publication Date:

16/10/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/12/2019

Expiration date:

08/12/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/10/2019

 

 

Name:

Eli Lilly and Company

Address:

Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Inventor

1

Name:

DONOHO, Gregory Paul

Address:

United States (US)

2

Name:

LIN, Aimee Karis

Address:

United States (US)

3

Name:

WACHECK, Volker

Address:

United States (US)

4

Name:

BECKMANN, Richard Paul

Address:

United States (US)

Priority

Priority Number:

201562267462 P

Priority Date:

15/12/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 31/4745; A61K 31/497; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

201942

Publication date:

16/10/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages